longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

REPL

REPL
----

LongbridgeAI

Replimune announces annual shareholder meeting

PUBT
Jul 13, 2026 at 09:21 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Replimune Group Inc. announced its 2026 annual shareholder meeting will be held virtually on September 15, 2026. Key agenda items include a vote to double authorized common shares from 150 million to 300 million, an advisory vote on executive compensation for the fiscal year ended March 31, 2026, and the ratification of PricewaterhouseCoopers as the independent auditor for the year ending March 31, 2027.

  • Replimune will hold its 2026 annual shareholder meeting virtually on Sept. 15, 2026. * Shareholders will vote on a charter amendment to double authorized common shares to 300,000,000 from 150,000,000. * Ballots also cover an advisory vote on executive pay for the year ended March 31, 2026. * Items include ratification of PricewaterhouseCoopers as independent auditor for the year ending March 31, 2027. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-083158), on July 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Login to unlock640characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Replimune

Replimune

REPL.US

Open

--

High

--

Low

--

Prev Close

--

P/ETTM

--

Market Cap

--